While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …

2023年9月8日 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...

3 天之前 · The Food and Drug Administration (FDA) has approved 2 additional vial sizes of Niktimvo ™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.. Niktimvo, a colony stimulating factor-1 receptor-blocking antibody, was approved in 2024 for the treatment of chronic graft-vs-host disease (GVHD) after failure of at least 2 prior lines of systemic therapy in adult and ...

2023年9月1日 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4

While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …

2020年1月7日 · Patients with gastroesophageal reflux disease (GERD) are frequently referred to gastroenterologists. As patients get older GERD is more common, with a prevalence of 20% or higher in the outpatient setting. 1 Elderly patients with GERD can clinically present differently than younger patients and their management may therefore vary. A review article published by Dr M Kurin of the Digestive ...

2025年1月13日 · Treatment with nivolumab significantly improved both overall survival (OS) and progression-free survival (PFS) in patients with advanced unresectable gastric or gastroesophageal junction cancer; however, the risk of severe adverse events (AEs) is considerable, particularly with monotherapy, according to study results published in BMC Gastroenterology.

2024年10月11日 · Clarithromycin administered via a dispersible tablet has a higher Helicobacter pylori (H pylori) eradication rate than clarithromycin sustained-release tablets, according to study results published in Therapeutic Advances in Gastroenterology.

2024年11月1日 · References: Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013 American Society for Metabolic and Bariatric Surgery.

2024年9月27日 · Over the summer, the US Food and Drug Administration (FDA) approved a biosimilar for Crohn disease (CD) and ulcerative colitis (UC), a blood-based test for colorectal cancer (CRC) screening, a new indication for heartburn associated with nonerosive gastroesophageal reflux disease (GERD), a new indication for UC, and a new indication for younger patients with progressive familial intrahepatic ...